Biomarker in Lung Diseases
- Conditions
- Lung Diseases
- Interventions
- Other: biomarker
- Registration Number
- NCT00989846
- Lead Sponsor
- Heidelberg University
- Brief Summary
Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy.
However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- age >= 18
- acute or chronic lung disease
Exclusion Criteria
- HIV
- lactation or gestation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description lung disease biomarker patients with various chronic or acute lung diseases
- Primary Outcome Measures
Name Time Method Serum biomarker expression 1 month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
🇩🇪Heidelberg, Germany